Últimas noticias sobre Health Catalyst (NASDAQ:HCAT) Bolsa

HEALTH CATALYST INC

Health Catalyst

Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

Health Catalyst Inc

<a href="https://www.hhs.gov/press-room/hrsa-to-reform-organ-transplant-system.html#:~:text=It%20found%3A,serious%20ethical%20and%20legal%20questions" title="https://www.hhs.gov/press-room/hrsa-to-reform-organ-transplant-system.html#:~:text=It%20found%3A,serious%20ethical%20and%20legal%20questions">https://www.hhs.gov/press-room/hrsa-to-reform-organ-transplant-system.html#:~:text=It%20found%3A,serious%20ethical%20and%20legal%20questions</a>.

Biotech

News

General

CDNA

TMDX

UTHR

'HHS Finds Systemic Disregard for Sanctity of Life in Organ Transplant System; To Begin Reforming Organ Transplant System; HRSA's Independent Investigation Revealed Clear Negligence After Previous OPTN Board Claimed To Find No Major Concerns In Internal Review'

WIIM

CRWD

FTNT

PANW

SNOW

Shares of several cybersecurity-related stocks are trading higher amid a cyber attack on Microsoft's SharePoint servers.

Roth Capital analyst Rohit Kulkarni maintains Reddit (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>) with a Neutral and raises the price target from $130 to $145.

Price Target

Analyst Ratings

RDDT

Roth Capital Maintains Neutral on Reddit, Raises Price Target to $145

CGAU

PAAS

RGLD

SSRM

USAU

Shares of precious metal-related stocks are trading higher amid tariff uncertainty, which has weakened the US dollar and bond yields.

Piper Sandler analyst Crispin Love maintains Virtus Inv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VRTS#NYSE">VRTS</a>) with a Overweight and raises the price target from $211 to $234.

VRTS

Piper Sandler Maintains Overweight on Virtus Inv, Raises Price Target to $234

Macro Economic Events

Global

Economics

MSFT

Reuters Cites UK Government Saying Memorandum Of Understanding Between The UK And OpenAI On AI Opportunities; OpenAI May Also Explore Developing, AI-Enabled R&D Infrastructure In The UK; OpenAI And DSIT To Collaborate To Identify Opportunities For How Advanced AI Models Can Be Deployed Throughout Government & Private Sector

Shares of Galaxy Digital Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLXY#NASDAQ">GLXY</a>) are trading higher Monday after the company <a href="https://www.benzinga.com/trading-ideas/movers/25/07/46523447/galaxy-digital-stock-is-moving-higher-monday-whats-going-on">announced a partnership with K Wave Media</a>.
What To Know: The collaboration is intended to advance Bitcoin treasury strategies and provide access to greater institutional capital. The move positions Galaxy to strengthen its presence in the digital asset space through expanded financial partnerships.
The rally also followed a detailed valuation update from Piper Sandler analysts Patrick Moley and Will Copps, who maintained an Overweight rating on Galaxy shares with a $36 price target. In their note, the analysts provided a deep dive into the sum-of-the-parts valuation of Galaxy's business and evaluated multiple scenarios tied to the company's Helios data center operations in Texas.
The report highlighted that if Galaxy secures approval for its full 2.5 gigawatts of planned power capacity at the Helios site and contracts it at economics similar to its existing 600-megawatt deal with CoreWeave, the stock could be worth up to $43 per share. 
The valuation for the Helios data center business alone was estimated between $9.35 and $28.72 per share, depending on the total contracted capacity. Galaxy currently has approval for 800 megawatts of power at Helios and is awaiting regulatory clearance for an additional 1.7 gigawatts from ERCOT.
The analysts noted that the implied valuation range for Galaxy shares spans from $24 to $43, reflecting potential downside of around 13% and upside of about 59% based on recent trading levels. They also cautioned that risks include regulatory changes in the cryptocurrency market, Bitcoin price volatility, energy costs, and operational risks related to mining infrastructure.
Galaxy operates as a diversified digital asset firm, providing services across investment banking, trading, prime brokerage, and asset management. The company's stock moved higher on a mix of the strategic partnership announcement and the renewed analyst focus on its data center expansion potential.
GLXY Price Action: Galaxy Digital shares were up 8.51% at $29.44 at the time of writing, according to<a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2"> Benzinga pro.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/25/07/46526172/wall-street-today-gold-bessent-fed-sp500-monday-markets">Wall Street Extends Records, Gold Rallies To $3,400: What&#8217;s Moving Markets Monday?</a></li>
</ul>
Image Via Shutterstock.

Movers

GLXY

Galaxy Digital Shares Rise On Bitcoin Treasury Partnership And Analyst Valuation Outlook

Wayfair (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/W#NYSE">W</a>) is gearing up to release its second-quarter earnings before the market opens on August 4, with expectations of surpassing Street estimates for both sales and profitability.
On Monday, Bank of America Securities analyst Curtis Nagle reiterated a <a target="_blank" href="https://www.benzinga.com/quote/W/analyst-ratings" rel="noreferrer noopener">Neutral rating</a> on Wayfair, setting a price forecast of $60. Nagle&#8217;s projection of $3.15 billion in second-quarter sales surpasses the Street&#8217;s consensus of $3.12 billion.
This more bullish outlook is attributed to stronger-than-expected industry trends, increased inventory availability driven by higher utilization of Wayfair&#8217;s CastleGate system, and effective vendor-funded promotions.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/25/05/45147261/whats-going-on-with-wayfair-stock-on-thursday" rel="noreferrer noopener">Wayfair Stock Rises After Surprise Q1 Profit and Higher Sales Beat Expectations</a>
The analyst&#8217;s EBITDA estimate of $153 million also exceeds the Street&#8217;s $146 million, fueled by expectations of higher gross profit dollars due to greater flow-through and leverage from Selling, Operations, Technology, General &amp; Administrative expenses, particularly from a right-sizing of the company&#8217;s tech headcount.
Supporting these positive trends, Bank of America&#8217;s aggregated credit and debit card data indicated a slight improvement in online furniture spending, which declined by 0.8% year-over-year in the second quarter, compared to a 1.6% decline in the first quarter.
Nagle suggests that these improving trends could signify a pull-forward in demand and increased promotional spending, although this might potentially come at the expense of industry sales later in the year.
He further noted that accelerating web and app trends suggest Wayfair is continuing to gain market share, driven by better product availability and vendor-funded promotions. Consequently, Nagle raised his second-quarter sales estimate by 1% to $3.15 billion and his EBITDA estimate by 2%.
Looking ahead to the third quarter, Nagle also increased his sales estimate by 1% to $2.86 billion, which aligns closely with the Street&#8217;s estimate of $2.87 billion.
This adjustment reflects the better-than-expected performance of consumer spending and the broader furnishings category. Furthermore, concerns regarding tariffs appear to be easing following Vietnam&#8217;s trade deal, despite an August 1 deadline.
The extended Black Friday in July event also indicates a healthy supply on the site, likely as vendors increasingly leverage CastleGate. Nagle sees this event as an additional opportunity for Wayfair to drive incremental sales. However, he maintained his fourth-quarter estimates, primarily due to tougher year-over-year comparisons.
While tariff concerns are abating, they remain a significant point of discussion for Wayfair. As such, topics on the upcoming earnings call are likely to revolve around the potential impact of tariffs on second-half 2025 trends and how vendors are navigating these challenges, particularly through CastleGate, vendor-funded promotions, and renegotiations. Nagle observed that the current share price already reflects the potential upside from easing tariffs and healthy supply trends.
Price Action: Wayfair shares are trading lower by 1.51% to $55.59 at last check Monday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/general/social-media/25/04/44747892/amazon-wayfair-pinterest-win-analyst-backing-due-to-tariff-pause-supply-chain-relief-discretionary-spend-recovery" target="_blank" rel="noreferrer noopener">Amazon, Wayfair, Pinterest Win Analyst Backing Due To Tariff Pause, Supply Chain Relief, Discretionary Spend Recovery</a></li>
</ul>
Image via Shutterstock

Reiteration

Trading Ideas

Wayfair Poised For Q2 Sales Beat On Strong Inventory, Vendor Promotions

<h3>Gainers</h3>
<ul>
<li>ATA Creativity Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AACG#NASDAQ">AACG</a>) stock rose 28.0% to $1.05 during Monday's regular session. The market value of their outstanding shares is at $25.8 million. </li>
<li>Netclass Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTCL#NASDAQ">NTCL</a>) shares increased by 20.66% to $1.81. The market value of their outstanding shares is at $26.7 million. </li>
<li>XWELL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XWEL#NASDAQ">XWEL</a>) stock rose 20.05% to $1.29. The market value of their outstanding shares is at $5.6 million. </li>
<li>Wag Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PET#NASDAQ">PET</a>) shares increased by 14.38% to $0.15. The company's market cap stands at $6.4 million. </li>
<li>Perfect Moment (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/PMNT#AMEX">PMNT</a>) stock rose 13.95% to $0.37. </li>
<li>MaxsMaking (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAMK#NASDAQ">MAMK</a>) stock increased by 12.64% to $2.85. The company's market cap stands at $42.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Barnes &amp; Noble Education (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BNED#NYSE">BNED</a>) shares declined by 18.8% to $9.12 during Monday's regular session. The company's market cap stands at $382.4 million. </li>
<li>QuantumScape (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QS#NYSE">QS</a>) stock fell 13.91% to $12.6. The company's market cap stands at $8.1 billion. </li>
<li>Jowell Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JWEL#NASDAQ">JWEL</a>) stock declined by 13.68% to $2.07. The market value of their outstanding shares is at $5.2 million. </li>
<li>Chijet Motor Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CJET#NASDAQ">CJET</a>) shares declined by 13.41% to $2.26. The company's market cap stands at $80.6 million. </li>
<li>Massimo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAMO#NASDAQ">MAMO</a>) shares fell 10.69% to $2.5. The company's market cap stands at $116.2 million. </li>
<li>Mullen Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MULN#NASDAQ">MULN</a>) stock decreased by 10.42% to $0.08. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AACG

BNED

CJET

JWEL

MAMK

MAMO

MULN

NTCL

PMNT

XWEL

12 Consumer Discretionary Stocks Moving In Monday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>ZimVie (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZIMV#NASDAQ">ZIMV</a>) shares rose 122.2% to $18.75 during Monday's regular session. The market value of their outstanding shares is at $235.6 million. </li>
<li>180 Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATNF#NASDAQ">ATNF</a>) shares increased by 56.11% to $2.94. The company's market cap stands at $11.3 million. </li>
<li>GlucoTrack (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GCTK#NASDAQ">GCTK</a>) stock moved upwards by 37.04% to $7.99. The company's market cap stands at $3.3 million. </li>
<li>Redhill Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDHL#NASDAQ">RDHL</a>) stock increased by 33.82% to $2.49. The market value of their outstanding shares is at $4.2 million. </li>
<li>TNF Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNFA#NASDAQ">TNFA</a>) shares moved upwards by 29.94% to $0.11. The market value of their outstanding shares is at $1.2 million. </li>
<li>Autonomix Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMIX#NASDAQ">AMIX</a>) shares rose 28.48% to $2.03. The company's market cap stands at $6.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Clearside Biomedical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLSD#NASDAQ">CLSD</a>) shares decreased by 24.2% to $0.31 during Monday's regular session. The company's market cap stands at $31.7 million. </li>
<li>Windtree Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WINT#NASDAQ">WINT</a>) shares declined by 20.18% to $0.95. The market value of their outstanding shares is at $13.7 million. </li>
<li>BioVie (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIVI#NASDAQ">BIVI</a>) shares decreased by 14.85% to $7.66. The market value of their outstanding shares is at $16.7 million. </li>
<li>Sonnet BioTherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SONN#NASDAQ">SONN</a>) stock declined by 13.27% to $5.36. The market value of their outstanding shares is at $19.5 million. </li>
<li>Evotec (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVO#NASDAQ">EVO</a>) shares decreased by 13.15% to $3.7. The company's market cap stands at $1.5 billion. </li>
<li>Bruker (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRKR#NASDAQ">BRKR</a>) shares fell 12.24% to $35.59. The market value of their outstanding shares is at $6.1 billion. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMIX

ATNF

BIVI

BRKR

CLSD

GCTK

RDHL

SONN

TNFA

WINT

ZIMV

12 Health Care Stocks Moving In Monday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Rich Sparkle Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANPA#NASDAQ">ANPA</a>) shares moved upwards by 25.1% to $9.77 during Monday's regular session. The market value of their outstanding shares is at $97.6 million. </li>
<li>Greenwave Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GWAV#NASDAQ">GWAV</a>) stock moved upwards by 22.25% to $0.28. The company's market cap stands at $13.0 million. </li>
<li>Stem (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STEM#NYSE">STEM</a>) stock rose 21.9% to $16.46. The company's market cap stands at $112.2 million. </li>
<li>AgEagle Aerial Sys (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/UAVS#AMEX">UAVS</a>) stock increased by 19.3% to $2.41. The market value of their outstanding shares is at $28.1 million. </li>
<li>Beam Glb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BEEM#NASDAQ">BEEM</a>) stock rose 19.18% to $3.05. The company's market cap stands at $39.4 million. </li>
<li>Clean Energy Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CETY#NASDAQ">CETY</a>) stock rose 15.23% to $0.27. The company's market cap stands at $14.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Erayak Power Solution Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAYA#NASDAQ">RAYA</a>) shares decreased by 90.0% to $0.31 during Monday's regular session. The market value of their outstanding shares is at $137.8 million. </li>
<li>OceanPal (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OP#NASDAQ">OP</a>) stock fell 57.73% to $0.69. The company's market cap stands at $12.4 million. </li>
<li>Micropolis Hldgs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MCRP#AMEX">MCRP</a>) shares fell 13.39% to $2.2. The market value of their outstanding shares is at $88.6 million. </li>
<li>FGI Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FGI#NASDAQ">FGI</a>) stock fell 13.0% to $0.8. The company's market cap stands at $8.8 million. </li>
<li>Knightscope (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KSCP#NASDAQ">KSCP</a>) stock declined by 11.9% to $8.89. The market value of their outstanding shares is at $69.6 million. </li>
<li>Hydrofarm Holdings Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HYFM#NASDAQ">HYFM</a>) shares fell 10.69% to $3.88. The company's market cap stands at $20.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ANPA

BEEM

CETY

GWAV

HYFM

KSCP

MCRP

RAYA

STEM

UAVS

12 Industrials Stocks Moving In Monday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>ReAlpha Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRE#NASDAQ">AIRE</a>) shares moved upwards by 189.5% to $0.55 during Monday's regular session. The market value of their outstanding shares is at $10.6 million. </li>
<li>Mobix Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOBX#NASDAQ">MOBX</a>) stock rose 47.5% to $1.27. The company's market cap stands at $46.0 million. </li>
<li>Trident Digital Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TDTH#NASDAQ">TDTH</a>) shares increased by 34.96% to $1.93. The market value of their outstanding shares is at $92.3 million. </li>
<li>Navitas Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVTS#NASDAQ">NVTS</a>) stock increased by 31.81% to $8.95. The market value of their outstanding shares is at $1.3 billion. </li>
<li>Veritone (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERI#NASDAQ">VERI</a>) stock rose 22.34% to $2.77. The market value of their outstanding shares is at $105.6 million. </li>
<li>Astera Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAB#NASDAQ">ALAB</a>) shares increased by 19.02% to $121.56. The company's market cap stands at $16.8 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>ClearOne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLRO#NASDAQ">CLRO</a>) stock decreased by 15.2% to $6.69 during Monday's regular session. The company's market cap stands at $13.6 million. </li>
<li>Aeva Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEVA#NASDAQ">AEVA</a>) stock decreased by 14.85% to $27.45. The company's market cap stands at $1.7 billion. </li>
<li>Argo Blockchain (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARBK#NASDAQ">ARBK</a>) stock declined by 14.65% to $0.43. The company's market cap stands at $31.9 million. </li>
<li>Red Cat Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCAT#NASDAQ">RCAT</a>) stock declined by 12.38% to $9.88. The company's market cap stands at $1.1 billion. </li>
<li>Nano Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NA#NASDAQ">NA</a>) stock declined by 12.07% to $7.04. The company's market cap stands at $188.5 million. </li>
<li>Robot Consulting Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAWR#NASDAQ">LAWR</a>) shares declined by 11.16% to $3.31. The market value of their outstanding shares is at $170.9 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AEVA

AIRE

ALAB

ARBK

CLRO

LAWR

MOBX

NVTS

RCAT

TDTH

VERI

12 Information Technology Stocks Moving In Monday's Intraday Session

Rumble (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUM#NASDAQ">RUM</a>) has gained momentum over the past month, drawing increased investor attention. Here&#8217;s a look at <a href="https://www.benzinga.com/node/46480518">what&#8217;s going on.</a>
What To Know: In late June, Rumble CEO Chris Pavlovski posted on X that the company aims to complete two major projects this year: Rumble Wallet and Rumble Shorts, the platform's short-form video segment. The company was also added to the Russell 2000 and Russell 3000 indexes.
In early July, Pavlovski posted on X that Rumble Ads (RAC) received a major update, including a revamped campaign creation interface and new intelligent targeting features. He said the improved targeting across Rumble's extended network boosted campaign performance by as much as 400% during testing.
On Thursday, the company announced on X that it is assembling a specialized machine learning and AI team to lead development across search functions, content recommendations, creator tools and Rumble Shorts.
Separately, the company announced that it appointed Ian O&#8217;Donnell as Vice President for Rumble Cloud. O&#8217;Donnell, a 20-year tech sales and marketing veteran, previously held roles at Google Cloud, Microsoft and Accelerate 360. The hire comes as Rumble expands its cloud services, which serve clients including the Miami Dolphins, Tampa Bay Buccaneers and the government of El Salvador.
How To Buy Rumble Stock
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Rumble&#8217;s case, it is in the Communication Services sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
See Also: <a href="https://www.benzinga.com/markets/economic-data/25/07/46521011/trump-stocks-bonds-foreign-inflows-record">Trump&#8217;s Economy Is Riding A Tsunami Of Inflows — So Much For &#8216;Sell America&#8217;</a>
RUM Price Action: At the time of writing, Rumble shares are trading 3.96% higher at $10.12, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Image via Shutterstock

Rumble Stock Is Trending This Month: What's Going On?

DeFi Technologies Inc. (the "Company" or "DeFi Technologies") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DEFT#NASDAQ">DEFT</a>) (CBOE CA: DEFI) (GR: R9B), a financial technology company bridging the gap between traditional capital markets and decentralized finance, today announced that the Company's common stock is now available for options trading on the Nasdaq Options Market ("Nasdaq").
Trading in DeFi Technologies' options commenced on June 21, 2025 under the ticker symbol "DEFT" and include a range of standard expiration dates and strike prices. This listing of options is expected to expand investor access and may enhance liquidity in the Company's shares, providing investors with added flexibility to manage risk, leverage positions and express views on the Company's future stock performance. DeFi Technologies believes this milestone reflects continued growth in investor interest and confidence in the Company's long-term strategic outlook.
Options trading on DeFi Technologies is available through the Options Clearing Corporation ("OCC") and will be subject to standard rules and regulations established by Nasdaq and the OCC.

DEFT

DeFi Technologies Begins Options Trading On Nasdaq, Expanding Investor Access And Liquidity

Shares of Webull Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BULL#NASDAQ">BULL</a>) are trading lower Monday afternoon after the company detailed a new committed equity financing agreement in an SEC filing on Friday. While the deal provides significant potential capital, it also raises concerns about shareholder dilution.
What To Know: The <a href="https://www.benzinga.com/pressreleases/25/07/n46465772/webull-corporation-to-consolidate-crypto-entities">filing</a> outlines a standby equity purchase agreement with an affiliate of Yorkville Advisors. Under the agreement, Webull has the right, but not the obligation, to sell up to $1 billion of its Class A ordinary shares to the investor over a 36-month period. The shares would be sold at a 2.5% discount to the market price.
Webull is registering the potential resale of over 75 million shares by the investor, which the filing notes represents approximately 15.5% of Webull&#8217;s total ordinary shares currently outstanding. 
The prospectus <a href="https://www.benzinga.com/pressreleases/25/07/n46465772/webull-corporation-to-consolidate-crypto-entities">warns</a> that the sale of these shares, or the perception that sales could occur, &#8220;could result in a significant decline in the public trading price of our securities&#8221;.
This news followed a more positive announcement last Thursday, when Webull <a href="https://www.benzinga.com/pressreleases/25/07/n46465772/webull-corporation-to-consolidate-crypto-entities">detailed</a> its plan to reintroduce cryptocurrency trading for its global customers. The company is reintegrating its Webull Pay subsidiary and intends to launch crypto trading services in the United States in the third quarter.
Price Action: According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, BULL shares are trading lower by 7.4% to $15.64 Monday afternoon. The stock has a 52-week high of $79.56 and a 52-week low of $10.18.
Read Also: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46524833/ethereum-is-at-the-forefront-of-the-financial-services-revolution-bernstein-says">Ethereum Is At The Forefront Of The Financial Services Revolution, Bernstein Says</a>
<h2 class="wp-block-heading">How To Buy BULL Stock</h2>
By now you're likely curious about how to participate in the market for Webull &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
In the case of Webull, which is trading at $16.02 as of publishing time, $100 would buy you 6.24 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
Image: Shutterstock

BULL

Webull Stock Slides On $1 Billion Equity Financing Deal And Dilution Concerns

NVIDIA Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) CEO Jensen Huang received a rockstar reception in Beijing during his most recent visit last week which marked his third this year and solidified his celebrity<a href="https://www.benzinga.com/markets/equities/25/07/46509701/nvidias-jensen-huang-charms-china-with-ai-diplomacy-as-tariff-tensions-linger"> status in China.&nbsp;</a>
What To Know:&nbsp; Huang, CEO of the world&#8217;s most valuable company, was seen strolling the streets of the capital city, mingling with fans and signing autographs—including on his trademark leather jackets. He was also seen taking selfies and being widely recognized by a devoted fanbase.&nbsp;
Read Next: <a href="https://www.benzinga.com/real-estate/25/07/46522335/opendoor-stock-frenzy-continues-is-40-per-share-the-next-stop?utm_source=articleShare">Opendoor Stock Frenzy Continues—Is $40 Per Share The Next Stop?</a>
During his visit, Huang attended the China International Supply Chain Expo and described Chinese AI models<a href="https://www.benzinga.com/markets/tech/25/07/46462378/why-nvidias-jensen-huang-says-china-leads-in-open-source-ai"> from companies like</a> DeepSeek, Alibaba Group Holding Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) and Tencent as &#8220;world class&#8221; and praised the scale and sophistication of the Chinese supply chain.
Huang even applauded the capabilities of Nvidia's strategic rival Huawei.&nbsp;
&#8220;I think the fact of the matter is, anyone who discounts Huawei and anyone who discounts China&#8217;s manufacturing capability is deeply naive. This is a formidable company,&#8221; Huang told reporters, according to Reuters.&nbsp;
Why It Matters: Huang&#8217;s trip came as Nvidia <a href="https://www.benzinga.com/markets/tech/25/07/46457371/nvidia-reloads-china-jensens-pitch-let-me-sell-the-good-stuff">resumed sales of </a>its advanced H20 AI chips to China, after a temporary U.S. ban was reversed.&nbsp;
The H20 is a less advanced and specially designed chip to comply with U.S. export rules that limit certain technologies from being sent to China.
Huang also held meetings with top Chinese officials, including Vice Premier He Lifeng and Commerce Minister Wang Wentao, solidifying Nvidia's commitment to the Chinese market as it navigates the current U.S.-China trade tensions.
Huang said that he communicated transparently with U.S. officials prior to his visit and informed President Donald Trump and his cabinet about the planned trip. 
Huang said that President Trump told him to, "Have a great trip."
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46422009/rare-earth-royalty-meet-the-power-players-shaping-the-industry?utm_source=articleShare">Rare Earth Royalty: Meet The Power Players Shaping The Industry</a></li>
</ul>
Photo: Shutterstock

Large Cap

Tech

BABA

NVDA

Nvidia's CEO Hits Beijing Like A Rockstar, Stirs Jensen-Mania In China

Vicor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VICR#NASDAQ">VICR</a>) is gearing up to announce its quarterly earnings on Tuesday, 2025-07-22. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Vicor will report an earnings per share (EPS) of $0.18.
Anticipation surrounds Vicor's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Overview of Past Earnings</h3>
The company's EPS missed by $0.23 in the last quarter, leading to a 23.13% drop in the share price on the following day.
Here's a look at Vicor's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.29</td>
<td>0.20</td>
<td>0.14</td>
<td>0.06</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.06</td>
<td>0.23</td>
<td>0.26</td>
<td>-0.03</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-23.0%</td>
<td>23.0%</td>
<td>14.000000000000002%</td>
<td>0.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1753117369_0.png" alt="eps graph" />
<h3>Performance of Vicor Shares</h3>
Shares of Vicor were trading at $47.51 as of July 18. Over the last 52-week period, shares are up 26.67%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/VICR/earnings">To track all earnings releases for Vicor visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

VICR

An Overview of Vicor's Earnings

Trustmark (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRMK#NASDAQ">TRMK</a>) will release its quarterly earnings report on Tuesday, 2025-07-22. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Trustmark to report an earnings per share (EPS) of $0.86.
Trustmark bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Overview of Past Earnings</h3>
In the previous earnings release, the company beat EPS by $0.06, leading to a 0.24% increase in the share price the following trading session.
Here's a look at Trustmark's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.82</td>
<td>0.83</td>
<td>0.82</td>
<td>0.62</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.88</td>
<td>0.92</td>
<td>0.84</td>
<td>0.66</td>
</tr>
<tr>
<td>Price Change %</td>
<td>0.0%</td>
<td>2.0%</td>
<td>-0.0%</td>
<td>-2.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1753117360_0.png" alt="eps graph" />
<h3>Performance of Trustmark Shares</h3>
Shares of Trustmark were trading at $38.55 as of July 18. Over the last 52-week period, shares are up 13.18%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/TRMK/earnings">To track all earnings releases for Trustmark visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

TRMK

Insights into Trustmark's Upcoming Earnings

<a href="https://www.ft.com/content/5ef3b1e2-20d0-4365-8e15-a816d49bc5c8" title="https://www.ft.com/content/5ef3b1e2-20d0-4365-8e15-a816d49bc5c8">https://www.ft.com/content/5ef3b1e2-20d0-4365-8e15-a816d49bc5c8</a>

Politics

"OpenAI And UK Sign 'Strategic Partnership' In Investment Push" - Financial Times

Renasant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNST#NYSE">RNST</a>) will release its quarterly earnings report on Tuesday, 2025-07-22. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Renasant to report an earnings per share (EPS) of $0.74.
Investors in Renasant are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Past Earnings Performance</h3>
During the last quarter, the company reported an EPS beat by $0.05, leading to a 8.66% increase in the share price on the subsequent day.
Here's a look at Renasant's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.61</td>
<td>0.61</td>
<td>0.63</td>
<td>0.66</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.66</td>
<td>0.73</td>
<td>0.70</td>
<td>0.69</td>
</tr>
<tr>
<td>Price Change %</td>
<td>9.0%</td>
<td>1.0%</td>
<td>5.0%</td>
<td>-2.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1753117350_0.png" alt="eps graph" />
<h3>Performance of Renasant Shares</h3>
Shares of Renasant were trading at $38.8 as of July 18. Over the last 52-week period, shares are up 6.59%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/RNST/earnings">To track all earnings releases for Renasant visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

RNST

A Look Ahead: Renasant's Earnings Forecast

Contracts

Press Releases

Signature Healthcare to Enhance Analytics by Leveraging Health Catalyst Ignite™

Health Catalyst Announces ~$5 Million Stock Repurchase

Ardent Health Appoints Robert DeMichiei to Board of Directors

Health Catalyst Releases Data and Analytics Solution Designed for Community, Regional, and Specialty Health Systems: Health Catalyst Ignite Spark™

Health Catalyst to Announce First Quarter 2025 Operating Results and Host Conference Call on Wednesday, May 7, 2025

Health Catalyst Announces Strategic Partnership with Microsoft to Accelerate AI Adoption and Transformation for Care Delivery Organizations

Health Catalyst Reports First Quarter 2025 Results

Health Catalyst to Participate in Upcoming Investor Conferences

Accelerating Measurable Improvement Through Actionable Insights: Health Catalyst Announces the Release of 10 AI-Integrated Data Toolkits on Databricks Marketplace

Health Catalyst to Announce Second Quarter 2025 Operating Results and Host Conference Call on Thursday, August 7, 2025

Comments

Health Catalyst

Noticias

Últimas noticias sobre Health Catalyst (NASDAQ:HCAT) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL